Experience

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Livent Corporation of $225 million aggregate principal amount of its 4.125%…

Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S offering of $600 million aggregate principal amount of 1.960% senior green notes due…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Zscaler, Inc. of $1.15 billion aggregate principal amount of its 0.125%…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Viasat, Inc. of $400 million aggregate principal amount of its 6.500%…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $650 million aggregate principal amount of 1.150% notes due 2028 and $650…

Davis Polk advised the representative of the initial purchasers of a Rule 144A/Regulation S offering by Acadia Healthcare Company, Inc. of $450 million aggregate principal amount of its 5…

Davis Polk advised Amdocs Limited on its $650 million SEC-registered debt offering of 2.583% notes due 2030.   Amdocs Limited is a leading software and services provider to…

Davis Polk advised the dealer managers in connection with Danske Bank A/S’s offer to exchange any and all of its outstanding 5.000% non-preferred senior notes due 2022 for its newly issued…

Davis Polk advised the representatives of the underwriters, in connection with the offering of $4.5 billion aggregate principal amount of notes issued by Merck & Co., Inc. The…

We are advising Digicel in connection with the transactions